Bradley Canino
Stock Analyst at Stifel
(1.56)
# 3,434
Out of 5,162 analysts
82
Total ratings
32.88%
Success rate
-4.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bradley Canino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Maintains: Buy | $46 → $38 | $13.70 | +177.37% | 4 | Dec 2, 2025 | |
| SNDX Syndax Pharmaceuticals | Reinstates: Buy | $44 | $23.39 | +88.11% | 7 | Sep 10, 2025 | |
| BDTX Black Diamond Therapeutics | Maintains: Buy | $16 → $15 | $2.19 | +584.93% | 5 | Mar 7, 2025 | |
| ALXO ALX Oncology Holdings | Maintains: Hold | $3 → $1.5 | $1.99 | -24.62% | 8 | Mar 7, 2025 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $23 → $19 | $13.60 | +39.71% | 2 | Feb 28, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $27 → $23 | $10.64 | +116.17% | 5 | Feb 27, 2025 | |
| ARVN Arvinas | Maintains: Buy | $63 → $51 | $12.12 | +320.97% | 6 | Feb 12, 2025 | |
| KURA Kura Oncology | Downgrades: Hold | $26 → $19 | $8.78 | +116.40% | 6 | Oct 14, 2024 | |
| CELC Celcuity | Maintains: Buy | $39 → $42 | $114.19 | -63.22% | 4 | Oct 7, 2024 | |
| SMMT Summit Therapeutics | Maintains: Buy | $25 → $40 | $16.56 | +141.55% | 4 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $135 | $97.25 | +38.82% | 4 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $11.69 | +71.09% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.55 | +545.16% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $10 | $2.76 | +262.98% | 17 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $2.86 | +390.37% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $55 | $79.76 | -31.04% | 4 | Feb 23, 2024 |
Janux Therapeutics
Dec 2, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $13.70
Upside: +177.37%
Syndax Pharmaceuticals
Sep 10, 2025
Reinstates: Buy
Price Target: $44
Current: $23.39
Upside: +88.11%
Black Diamond Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $2.19
Upside: +584.93%
ALX Oncology Holdings
Mar 7, 2025
Maintains: Hold
Price Target: $3 → $1.5
Current: $1.99
Upside: -24.62%
Cullinan Therapeutics
Feb 28, 2025
Maintains: Buy
Price Target: $23 → $19
Current: $13.60
Upside: +39.71%
Relay Therapeutics
Feb 27, 2025
Maintains: Buy
Price Target: $27 → $23
Current: $10.64
Upside: +116.17%
Arvinas
Feb 12, 2025
Maintains: Buy
Price Target: $63 → $51
Current: $12.12
Upside: +320.97%
Kura Oncology
Oct 14, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $8.78
Upside: +116.40%
Celcuity
Oct 7, 2024
Maintains: Buy
Price Target: $39 → $42
Current: $114.19
Upside: -63.22%
Summit Therapeutics
Sep 25, 2024
Maintains: Buy
Price Target: $25 → $40
Current: $16.56
Upside: +141.55%
Sep 16, 2024
Maintains: Buy
Price Target: $115 → $135
Current: $97.25
Upside: +38.82%
Sep 6, 2024
Initiates: Buy
Price Target: $20
Current: $11.69
Upside: +71.09%
Aug 8, 2024
Initiates: Buy
Price Target: $10
Current: $1.55
Upside: +545.16%
Jun 18, 2024
Maintains: Buy
Price Target: $32 → $10
Current: $2.76
Upside: +262.98%
May 9, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $2.86
Upside: +390.37%
Feb 23, 2024
Maintains: Buy
Price Target: $35 → $55
Current: $79.76
Upside: -31.04%